ANI Pharmaceuticals, Inc. · NASDAQ:ANIP
Lalwani Nikhil sold 5,400 ANI Pharmaceuticals, Inc. shares (Form 4)
Traded Nov 16 to Nov 18, 2026 · Filed Nov 18, 2026
From Nov 16 to Nov 18, 2026, Lalwani Nikhil (Director, PRESIDENT & CEO) sold 5,400 ANI Pharmaceuticals, Inc. shares at an average US$71.22 for US$385K under a trading plan, leaving 328,289 shares. Filed Nov 18, 2026 (Form 4).
- Sold
- 5,400 shares
- Price
- US$71.22 average (US$71.16 to US$71.40)
- Value
- US$385K
- Holding after
- 328,289 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, PRESIDENT & CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | Common Stock | Sale | 1,318 | US$71.40 | 332,371 | Direct |
| Nov 18, 2026 | Common Stock | Sale | 4,082 | US$71.16 | 328,289 | Direct |
Source
Download original · View original at SEC
Related
- ANI Pharmaceuticals, Inc.
- Lalwani Nikhil
- ANI Pharmaceuticals, Inc. shareholders
- Form 4 · Lalwani Nikhil · Oct 16, 2026
- Form 4 · Lalwani Nikhil · Sep 16, 2026
- Form 4 · Lalwani Nikhil · Aug 26, 2026
- Form 4 · Lalwani Nikhil · May 13, 2026
- Form 4 · Cook Meredith · Nov 13, 2026
- Form 4 · Carey Stephen P. · Oct 30, 2026
- Form 4 · Cook Meredith · Oct 13, 2026
- Form 4 · Carey Stephen P. · Sep 30, 2026
- Form 4 · Cook Meredith · Sep 14, 2026